Cargando…
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea
BACKGROUND: Although the 13-valent pneumococcal conjugate vaccine (PCV13) showed good efficacy against pneumococcal disease in the the CAPiTA trial, the 23-valent pneumococcal polysaccharide vaccination (PPSV23) program has been ongoing for older adults aged ≥ 65 years in Korea since May of 2013. Th...
Autores principales: | Heo, Jung Yeon, Seo, Yu Bin, Choi, Won Suk, Lee, Jacob, Noh, Ji Yun, Jeong, Hye Won, Kim, Woo Joo, Kim, Min Ja, Lee, Hee Young, Song, Joon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428995/ https://www.ncbi.nlm.nih.gov/pubmed/28498857 http://dx.doi.org/10.1371/journal.pone.0177342 |
Ejemplares similares
-
Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors
por: Song, Joon Young, et al.
Publicado: (2013) -
Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017) -
Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis
por: Heo, Jung Yeon, et al.
Publicado: (2018) -
1003. Clinical Implications of Emerging Nonvaccine-Serotype Invasive Pneumococcal Disease Among Adults in the Republic of Korea in the Era of Protein-Conjugated Pneumococcal Vaccine
por: Kim, Jong Hun, et al.
Publicado: (2018) -
Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea
por: Yun, Jae-Won, et al.
Publicado: (2019)